Company news

Avecho Biotechnology Limited news in 2024

Avecho Biotechnology Limited's news releases, calls and decks from 2024, newest first.

View company

September 2024 Quarterly Activities Report & Appendix 4C

October 28, 2024

June 2024 Quarterly Activities Report & Appendix 4C

July 30, 2024

Chair's Address and CEO Presentation

May 30, 2024

First Patient dosed in Phase III insomnia trial

May 15, 2024

March 2024 Quarterly Activities Report & Appendix 4C

April 30, 2024

Avecho commences Phase III insomnia trial

March 25, 2024

Avecho meets TGA ahead of Phase III Clinical Trial

March 13, 2024

AVE receives final ethics approval for Phase III CBD trial

March 6, 2024

Appendix 4E and Annual Report 31 December 2023

February 29, 2024

December 2023 Quarterly Activities Report & Appendix 4C

January 30, 2024

Decks in 2024